Recently, new types of interferon (IFN) agents, such as pegylated IFN (PEG-IFN) and consensus IFN, have been developed for strong therapeutic effect and used in clinical stage. PEG-IFN, which is the conjugation of IFN and polyethylene glycol, was designed to long circulate in blood and decrease antibody production. Consensus IFN was designed to combine amino acid frequently appeared in IFN-alpha subtypes. Although they improved IFN therapy, it is also important to pay attention to side effect. Characteristics of new type IFN agents were summarized focused on their pharmaceutical designs.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
ifn agents
8
consensus ifn
8
ifn
7
[pharmaceutical device
4
device ifn]
4
ifn] types
4
types interferon
4
interferon ifn
4
agents pegylated
4
pegylated ifn
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!